World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT01083784
Date of registration: 07/03/2010
Primary sponsor: Samsung Medical Center
Public title: The Benefit of Prophylactic Anticonvulsant in Post Cardiac Arrest Syndrome With Induced Mild Hypothermia
Scientific title: The Benefit of Prophylactic Anticonvulsant in Post Cardiac Arrest Syndrome With Induced Mild Hypothermia
Date of first enrolment: March 2010
Target sample size: 60
Recruitment status: Enrolling by invitation
URL:  http://clinicaltrials.gov/show/NCT01083784
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment  
Countries of recruitment
Korea, Republic of
Contacts
Name:   Min Seob Sim, Master
Address: 
Telephone:
Email:
Affiliation:  Dept. of Emergency Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine
Key inclusion & exclusion criteria

Inclusion Criteria:

- Age : over 18, under 80

- Witnessed arrest

- Successful first resuscitation (ROSC should be last for 20 min.)

- Coma or Semicoma state

- Mean arterial pressure > 60mmHg

- Peripheral Oxygen saturation > 85%

- Expected life span before cardiac arrest > 3 month.

- Performance scale before cardiac arrest > 3 month.

Exclusion Criteria:

- Cause of arrest

- Sepsis, Progression of malignancy, Trauma, Hemorrhagic shock

- Known Coagulopathy

- Major operation within 7 days

- Previous seizure history

- current use of valproate or clonazepam



Age minimum: 18 Years
Age maximum: 80 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Cardiac Arrest
Intervention(s)
Drug: Control group
Drug: Use of prophylactic anticonvulsants (valproate, clonazepam)
Primary Outcome(s)
electroencephalogram (EEG) [Time Frame: 72hr after cardiac arrest]
Secondary Outcome(s)
CPC score (cerebral performance category) score [Time Frame: 1month and 3 month after cardiac arrest]
Secondary ID(s)
2009-08-038
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history